Christina Carlander

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

Överläkare inom infektionssjukdomar vid Karolinska Universitetssjukhuset, subspecialiserad på hivvård. Jag är även Docent och Teamledare för Team HIV-comorbidity vid Enheten för infektionssjukdomar och dermatologi, Institutionen för Medicin Huddinge. Även knuten till Institutionen för Medicinsk Epidemiologi och Biostatistik vid KI, Solna.
Sedan 2021 är jag registerhållare för Kvalitetsregistret för HIV (InfCareHIV).

För ytterligare information vänligen se min engelska sida.

Artiklar

Journal article: VALUE IN HEALTH. 2024;27(12):s453
MSR80 Rare Outcome Analysis in Longitudinal Real-World Data: Methodological Insights From Switching HIV Treatment to 2 Versus 3-Drug Regimen in Sweden
Sörstedt E; Nduva G; Hiltunen S; Repits J; Månsson F; Mellgren Å; Fernvik E; Stubbs A; Schroeder M; Brännström J; Carlander C
Article: CLINICAL INFECTIOUS DISEASES. 2024;79(5):1242-1257
Trends in Mortality in People With Human Immunodeficiency Virus From 1999 through 2020: A Multicohort Collaboration
Tusch E; Ryom L; Pelchen-Matthews A; Mocroft A; Elbirt D; Oprea C; Gunthard HF; Staehelin C; Zangerle R; Suarez I; Vehreschild JJ; Wit F; Menozzi M; Monforte AD; Spagnuolo V; Pradier C; Carlander C; Suanzes P; Wasmuth J-C; Carr A; Petoumenos K; Borgans F; Bonnet F; De Wit S; El-Sadr W; Neesgaard B; Jaschinski N; Greenberg L; Hosein SR; Gallant J; Vannappagari V; Young L; Sabin C; Lundgren J; Peters L; Reekie J
Journal article: BLOOD. 2024;144(Supplement 1):4634
Severity of COVID-19 in Individuals with Chronic Lymphocytic Leukemia throughout the Pandemic in Sweden: A Nationwide Multiple Register Cohort Study Conducted from 2020 to 2023
Blixt L; Hedberg P; Sylvan SE; Möller IK; Lindahl H; Kahn F; Nilsdotter-Augustinsson Å; Fredrikson M; Nyström S; Rosenquist R; Bergman P; Carlander C; Aleman S; Österborg A; Hansson L
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024;:S0091-6749(24)01125-4
Inborn errors of immunity are associated with increased COVID-19-related hospitalization and intensive care compared to the general population.
Lindahl H; Kahn F; Nilsdotter-Augustinsson Å; Fredrikson M; Hedberg P; Killander Möller I; Hansson L; Blixt L; Eketorp Sylvan S; Österborg A; Aleman S; Carlander C; Nyström S; Bergman P
Article: EUROSURVEILLANCE. 2024;29(42):2400058
Sweden surpasses the UNAIDS 95-95-95 target: estimating HIV-1 incidence, 2003 to 2022
Lundgren E; Locke M; Romero-Severson E; Dimitrijevic M; Axelsson M; Andersson E; Carlander C; Brannstroem J; Norrgren H; Mansson F; Elvstam O; Gisslen M; Fohlin L; Sonnerborg A; Albert J; Leitner T
Article: LANCET HIV. 2024;11(10):e660-e669
Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration
Pantazis N; Sabin CA; Grabar S; van der Valk M; Jarrin I; van Sighem A; Meyer L; Carlander C; Gill J; Anne AV; Spire B; Tariq S; Burns F; Costagliola D; Ruiz-Burga E; Touloumi G; Porter K
Article: INFECTIOUS DISEASES. 2024;:1-14
Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in Sweden
Moller IK; Hedberg P; Wagner P; Lindahl H; Nystrom S; Blixt L; Sylvan SE; Nilsdotter-Augustinsson A; Osterborg A; Fredrikson M; Hansson L; Kahn F; Sparen P; Gisslen M; Naucler P; Bergman P; Aleman S; Carlander C
Article: HIV MEDICINE. 2024;25(9):1058-1074
Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men
Hutchinson J; Neesgard B; Kowalska J; Grabmeier-Pfistershammer K; Johnson M; Kusejko K; De Wit S; Wit F; Mussini C; Castagna A; Stecher M; Pradier C; Domingo P; Carlander C; Wasmuth J; Chkhartishvili N; Uzdaviniene V; Haberl A; Monforte AD; Garges H; Gallant J; Said M; Schmied B; van der Valk M; Konopnicki D; Jaschinski N; Mocroft A; Greenberg L; Burns F; Ryom L; Petoumenos K
Article: INFECTIOUS DISEASES. 2024;56(8):657-668
Prophylaxis and treatment of HIV infection in pregnancy, Swedish guidelines 2024
Naver L; Albert J; Carlander C; Gisslen M; Pettersson K; Soeria-Atmadja S; Sonnerborg A; Westling K; Yilmaz A; Pettersson K
Article: AIDS. 2023;37(13):2041-2048
Extracutaneous Kaposi sarcoma risk remains higher in people with HIV in the post-ART era.
Dinh S; Malmström S; Möller IK; Yilmaz A; Svedhem V; Carlander C
Article: HIV MEDICINE. 2023;24(10):1045-1055
COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study
Moller IK; Gisslen M; Wagner P; Sparen P; Carlander C
Article: BMJ OPEN. 2023;13(5):e070837
CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada
Ruiz-Burga E; Tariq S; Touloumi G; Gill J; Nicholls EJ; Sabin C; Mussini C; Meyer L; Anne AV; Carlander C; Grabar S; Jarrin I; Van der Valk M; Wittkop L; Spire B; Pantazis N; Burns FM; Porter K
Article: BMJ OPEN. 2023;13(3):e069688
Cohort profile: InfCareHIV, a prospective registry-based cohort study of people with diagnosed HIV in Sweden
Carlander C; Brannstrom J; Mansson F; Elvstam O; Albinsson P; Blom S; Mattsson L; Hovmoller S; Norrgren H; Mellgren A; Svedhem V; Gisslen M; Sonnerborg A
Article: AIDS. 2022;36(13):1829-1834
Associations between HIV viremia during antiretroviral therapy and cardiovascular disease
Elvstam O; Marrone G; Engstrom G; Nilsson PM; Carlander C; Treutiger CJ; Gisslen M; Bjorkman P
Article: CLINICAL INFECTIOUS DISEASES. 2022;74(7):1199-1207
Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area
Wangdahl A; Sonden K; Wyss K; Stenstrom C; Bjorklund D; Zhang J; Askling HH; Carlander C; Hellgren U; Farnert A
Article: AIDS. 2022;36(3):447-457
Failure to restore CD4⁺ cell count associated with infection-related and noninfection-related cancer
Malmstrom S; Wagner P; Yilmaz A; Svedhem V; Carlander C
Article: AIDS. 2021;35(14):2367-2374
Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment
Carlander C; Lagheden C; Eklund C; Kleppe SN; Dzabic M; Wagner P; Sparen P; Dillner J
Article: AIDS. 2021;35(1):115-123
Employment by HIV status, mode of HIV transmission and migrant status: a nation-wide population-based study
Carlander C; Wagner P; Yilmaz A; Sparen P; Svedhem V
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2020;29(12):2662-2668
HPV Types in Cervical Precancer by HIV Status and Birth Region: A Population-Based Register Study
Carlander C; Lagheden C; Eklund C; Kleppe SN; Dzabic M; Wagner P; Yilmaz A; Elfgren K; Sonnerborg A; Sparen P; Dillner J
Article: INFECTIOUS DISEASES. 2020;52(10):705-712
The clinical impact of implementing GenMark ePlex blood culture panels for around-the-clock blood culture identification; a prospective observational study
Krifors A; Radberg G; Golbob S; Omar Z; Svensson C; Heimer D; Carlander C
Article: AIDS. 2018;32(11):1475-1484
Suppressive antiretroviral therapy associates with effective treatment of high-grade cervical intraepithelial neoplasia
Carlander C; Wagner P; van Beirs A; Yilmaz A; Elfgren K; Dillner J; Sonnerborg A; Sparen P
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2018;51(5):733-738
Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
Sorstedt E; Carlander C; Flamholc L; Hejdeman B; Svedhem V; Sonnerborg A; Gisslen M; Yilmaz A
Article: BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2017;124(11):1680-1687
Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study
Carlander C; Marrone G; Brannstrom J; Yilmaz A; Elfgren K; Sparen P; Sonnerborg A
Article: INTERNATIONAL JOURNAL OF CANCER. 2016;139(7):1471-1479
Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden
Carlander C; Wagner P; Svedhem V; Elfgren K; Westling K; Sonnerborg A; Sparen P
Visa fler

Alla övriga publikationer

Preprint: MEDRXIV. 2023
HIV prevention and missed opportunities among people with recently acquired HIV infection: Α protocol for a systematic review
Karakosta A; Ruiz-Burga E; Tariq S; Touloumi G; Nicholls EJ; Pantazis N; Jarrin I; Van der Valk M; Sabin C; Mussini C; Meyer L; Anne AV; Carlander C; Grabar S; Wittkop L; Spire B; Gill J; Porter K; Burns F; Collaboration C
Letter: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2023;94(3):e5-e8
Metabolic and Bariatric Surgery for People Living With HIV-A Propensity-Matched Cohort Study
Stenberg E; Carlander C; Cao Y; Ottosson J; Naeslund E
Conference publication: HIV MEDICINE. 2023;24:696-697
Anchor drug associated with the odds of immunological recovery: A nation-wide register-based study between 2000 and 2022
Nilsson J; Elvstam O; Sorstedt E; Nowak P; Brannstrom J; Carlander C
Conference publication: HIV MEDICINE. 2023;24:686-688
Real-world estimation of SARSCoV-2 vaccination, infection and hospitalization in people living with HIV compared to people without HIV: A population-based cohort study by the CLHIP study group
Moller IK; Hedberg P; Sparen P; Gisslen M; Naucler P; Carlander C
Review: INFECTIOUS DISEASES. 2020;52(5):295-329
Antiretroviral treatment for HIV infection: Swedish recommendations 2019
Eriksen J; Carlander C; Albert J; Flamholc L; Gisslen M; Naver L; Svedhem V; Yilmaz A; Sonnerborg A
Conference publication: HIV MEDICINE. 2019;20:195-196
Employment of people living with HIV approaching that of the HIV-negative population irrespective of migrant status and sexual orientation
Carlander C; Wagner P; Sparen P; Svedhem V
Thesis / dissertation: 2018
Cervical intraepithelial neoplasia in migrant women living with HIV
Carlander, Christina
Review: INFECTIOUS DISEASES. 2018;50(7):495-506
Prophylaxis and treatment of HIV-1 infection in pregnancy - Swedish Recommendations 2017
Naver L; Albert J; Carlander C; Flamholc L; Gisslen M; Karlstrom O; Svedhem-Johansson V; Sonnerborg A; Westling K; Yilmaz A; Pettersson K
Letter: BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2017;124(11):1795
Re: Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study Reply
Carlander C
Review: INFECTIOUS DISEASES. 2017;49(1):1-34
Antiretroviral treatment for HIV infection: Swedish recommendations 2016
Eriksen J; Albert J; Blaxhult A; Carlander C; Flamholc L; Gisslen M; Josephson F; Karlstrom O; Naver L; Svedhem V; Yilmaz A; Sonnerborg A
Review: INFECTIOUS DISEASES. 2016;48(2):93-98
Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
Gaines H; Albert J; Axelsson M; Berglund T; Gisslen M; Sonnerborg A; Blaxhult A; Bogdanovic G; Brytting M; Carlander C; Flamholc L; Follin P; Haggar A; Hagstam P; Johansson M; Naver L; Blom JP; Samuelson A; Strom H; Sundqvist M; Johansson VS; Wisell KT; Tegnell A; Thorstensson R
Review: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2014;46(10):673-677
Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
Albert J; Berglund T; Gisslen M; Groon P; Sonnerborg A; Tegnell A; Alexandersson A; Berggren I; Blaxhult A; Brytting M; Carlander C; Carlson J; Flamholc L; Follin P; Haggar A; Hansdotter F; Josephson F; Karlstrom O; Liljeros F; Naver L; Pettersson K; Johansson VS; Svennerholm B; Tunback P; Widgren K
Review: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2014;46(6):401-411
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013
Naver L; Albert J; Bottiger Y; Carlander C; Flamholc L; Gisslen M; Josephson F; Karlstrom O; Lindborg L; Svedhem-Johansson V; Svennerholm B; Sonnerborg A; Yilmaz A; Pettersson K

Forskningsbidrag

Prevention och tidig upptäckt av cancer för personer med med hiv – vem och när?
Vetenskapsrådet
1 January 2025 - 31 December 2028
Nya metoder för att förebygga analcancer hos riskutsatta grupper: En tvärvetenskaplig, registerbaserad studie med fokus på screening och biomarkörer
Vetenskapsrådet
1 January 2025 - 31 December 2028
Comorbidity in people with HIV
The Gilead Sciences Nordic Fellowship, unrestricted
1 January 2023 - 1 January 2025
Immunological non-response despite viral suppression-incidence and risk factors
Swedish Doctors against AIDS Research foundation
1 January 2022 - 1 January 2025
Covid-19 vaccination in immunocompromised individuals: An interdisciplinary framework to gain clinical and mechanistic insight into durable immunity to SARS-CoV-2 infection
Swedish Research Council
1 June 2021 - 31 May 2025
Risk of severe COVID-19 in people living with HIV
The Gilead Sciences Nordic Fellowship, unrestricted
1 January 2020 - 1 January 2023
Employment status of people living with and without HIV in Sweden
Swedish Doctors against AIDS Research foundation
1 January 2019 - 1 January 2021

Anställningar

Anknuten till Forskning, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2024-2026
Adjungerad Adjunkt, Medicin, Huddinge, Karolinska Institutet, 2024-2025
Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2022-2025

Examina och utbildning

Docent, Infektionsmedicin, Karolinska Institutet, 2024
Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2019

Om mig

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI